The Yuan requests your support! Our content will now be available free of charge for all registered subscribers, consistent with our mission to make AI a human commons accessible to all. We are therefore requesting donations from our readers so we may continue bringing you insightful reportage of this awesome technology that is sweeping the world. Donate now
AI: Unleashing the drug discovery revolution for a healthier tomorrow
By Dilraj Kaur  |  Oct 13, 2023
AI: Unleashing the drug discovery revolution for a healthier tomorrow
Image courtesy of and under license from
AI has brought about a remarkable transformation in the realm of drug discovery, which was previously plagued by inefficiency and a significant failure rate. The historical inefficiencies in drug discovery are swiftly becoming a thing of the past, and the repercussions for the healthcare industry are monumental, as highlighted by Dr Dilraj Kaur, a bioinformatic scientist at the Institute of Cancer Research in London.

LONDON - Historically, the search for novel and efficient medications has been an expensive, time-consuming, and often unpredictable process. However, the quick - and accelerating - development of artificial intelligence (AI) in recent years is causing drug research to undergo dramatic change. This is largely a result of AI's ability to analyze enormous volumes of data, spot patterns, and forecast outcomes, ushering in a new era of expedited medication discovery. This article examines how AI is changing the drug discovery process, and also takes a look at some of its uses, difficulties, and potential benefits for the future of medicine.

AI’s impact on drug discovery

AI is proving to be a powerful tool in all aspects of drug discovery, enabled by diverse technologies such as machine learning (ML) and deep learning:

- Data analysis and insights: Starting in the age of Big Data, AI systems have become able to analyze and process complex biological, chemical, and clinical datasets, uncovering patterns and insights human researchers would likely miss. This capability is one of the most important in expediting the identification of possible medication candidates.

- Predictive modeling: AI creates predictive models that evaluate medication safety profiles, and forecast potential side effects and interactions between compounds and target proteins. Early-stage testing lowers the possibility of failure during later phases of medication development. One of the studies, PRRpred, deals with the prediction of pattern recognition receptors (PRRs) using evolutionary information. PRRs are an integral part of the immune system. PRRs are germline-encoded host sensors that detect molecules typical for certain pathogens. Their agonist/ligands act as i

The content herein is subject to copyright by The Yuan. All rights reserved. The content of the services is owned or licensed to The Yuan. Such content from The Yuan may be shared and reprinted but must clearly identify The Yuan as its original source. Content from a third-party copyright holder identified in the copyright notice contained in such third party’s content appearing in The Yuan must likewise be clearly labeled as such.
Continue reading
Sign up now to read this story for free.
- or -
Continue with Linkedin Continue with Google
Share your thoughts.
The Yuan wants to hear your voice. We welcome your on-topic commentary, critique, and expertise. All comments are moderated for civility.